SELEXIS SA

selexis-sa-logo

Selexis SA, a global life sciences company for drug discovery, cell line development and scale-up to manufacturing of therapeutic proteins.

#SimilarOrganizations #People #Website #More

SELEXIS SA

Industry:
Biotechnology Manufacturing

Founded:
2001-01-01

Address:
Leuven, Vlaams-Brabant, Belgium

Country:
Belgium

Website Url:
http://www.selexis.com

Status:
Active

Contact:
+41-22-308-9360

Email Addresses:
[email protected]


Similar Organizations

not_available_image

Oncalis AG

Oncalis AG operates as a biotech company.

Current Employees Featured

mark-w-womack_image

Mark W. Womack
Mark W. Womack CEO @ Selexis SA
CEO
2022-05-01

Official Site Inspections

http://www.selexis.com

  • Host name: 199.60.103.166
  • IP address: 199.60.103.166
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "Selexis SA"

Selexis - Crunchbase Company Profile & Funding

Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the โ€ฆSee details»

JSR Life Sciences Announces Operational Consolidation โ€ฆ

May 31, 2023 KBIโ€™s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers. Sunnyvale, Calif. -- (May 31, 2023) -- JSR Life Sciences today announced that โ€ฆSee details»

KBI Biopharma, Selexis SA Merge as One Organization

Jun 5, 2023 KBI Biopharma, Inc., a contract development and manufacturing organization (CDMO), and Selexis SA, a cell line development company, are consolidating as one organization under the KBI Biopharma name. The fusion โ€ฆSee details»

JSR Life Sciences Announces Operational Consolidation โ€ฆ

May 31, 2023 โ€œThe fusion of KBI and Selexis as one business advances KBI into an exciting strategic growth phase,โ€ said Tim Lowery, President of JSR Life Sciences. โ€œThis natural operational strategy shift is pivotal for KBI and Selexis โ€ฆSee details»

Press Release | JSR Life Sciences Agrees to Acquire Pioneering Cell ...

Jun 14, 2017 The Selexis technologies seamlessly integrate into the biologics development continuum, spanning discovery to commercialization. This allows us ¬โ€“ in conjunction with KBI โ€ฆSee details»

KBI Biopharma and Selexis Hold Joint Ribbon Cutting โ€ฆ

Jul 6, 2022 KBI Biopharma and Selexis ribbon cutting at their new state-of-the-art facility in Geneva, Switzerland, Tuesday, July 5, 2022 (from left to right Mark Lutgen, KBI Biopharma, VP of Global Engineering; Mario Rodriguez, Mayor, โ€ฆSee details»

Selexis SA - Plan-les-Ouates, Switzerland - bionity.com

Selexis is a science-driven organization, founded on the academic interests and discoveries of its core scientific team in molecular biology, cellular physiology, and genetic engineering, and is โ€ฆSee details»

Selexis SA - Crunchbase Company Profile & Funding

Organization. Selexis SA . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Selexis SA operates as a global life science company. Acquired by . ...See details»

Selexis 2025 Company Profile: Valuation, Investors, โ€ฆ

Selexis General Information Description. Operator of a life science company intended to develop cell line generation technologies that improve the expression of recombinant proteins in mammalian cells. The company's cell line โ€ฆSee details»

Selexis SA - VentureRadar

Swiss-based Selexis SA is a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development. ... Find out more about Selexis SA, Biotech, โ€ฆSee details»

Delving into the Latest Updates on Selexis SA with Synapse

KBIโ€™s new model will enhance operational efficiencies, drive strategic clarity, and accelerate innovation for global biopharma customers SUNNYVALE, Calif.--(BUSINESS WIRE)-- JSR โ€ฆSee details»

Selexis - Overview, News & Similar companies | ZoomInfo.com

Mar 21, 2023 Who is Selexis. Selexis SA, a JSR Life Sciences company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions โ€ฆSee details»

Selexis SA - Drug pipelines, Patents, Clinical trials - Synapse

Explore Selexis SA with its drug pipeline, therapeutic area, technology platform, 25 news, Disease Domain:Immune System Diseases, Technology Platform:Monoclonal ...See details»

Selexis Company Profile - Office Locations, Competitors ... - Craft

Selexis is a company engaged in mammalian cell line development technologies. It focuses on molecular biology, cellular physiology, and genetic engineering. The company serves drug โ€ฆSee details»

Selexis - Products, Competitors, Financials, Employees, โ€ฆ

Selexis is a biotech company that specializes in mammalian (suspension-adapted CHO-K1) cell line generation. It specializes in drug discovery, cell line development, and biopharmaceutical โ€ฆSee details»

Selexis and KBI Biopharma Enter into Agreements with Immatics โ€ฆ

Jun 30, 2021 More information is available at www.selexis.com. About KBI Biopharma, Inc. KBI Biopharma, a JSR Life Sciences company, is an award-winning biopharmaceutical contract โ€ฆSee details»

Mark Womack - CEO at Selexis - The Org

An organization builder with a track record of delivering unprecedented growth and profit in every role, Mark Womack is the Chief Executive Officer of Sele. ... Before joining Selexis, Mark โ€ฆSee details»

Selexis S.A. - Great Place To Work

Selexis employees are the โ€œX Factorโ€ that make our bold company vision a reality. Here, successes and failures are shared by all. From the day they join us, our employees know they โ€ฆSee details»

Selexis - Contacts, Employees, Board Members, Advisors & Alumni

Selexis has 5 current employee profiles, including VP, Licensing and Business Development Yemi Onakunle. Yemi Onakunle VP, Licensing and Business Development Alberto Garotti Chief โ€ฆSee details»

Selexis - Swiss Biotech

The advanced technologies in protein expression by Selexis provide biotech and pharmaceutical companies with a rapid, stable, and cost-effective solution for the production of recombinant โ€ฆSee details»

linkstock.net © 2022. All rights reserved